Envoy Medical Inc (COCH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -26,499 | -13,253 | -15,923 | -4,446 | 15,552 |
| Depreciation Amortization | 56 | 27 | 75 | 49 | 176 |
| Accounts receivable | -14 | -22 | 47 | -9 | N/A |
| Accounts payable and accrued liabilities | 1,357 | 1,018 | 342 | -241 | 266 |
| Other Working Capital | 1,116 | 726 | -160 | -650 | 1,150 |
| Other Operating Activity | 16,939 | 8,493 | 6,814 | -1,129 | -18,317 |
| Operating Cash Flow | $-7,045 | $-3,011 | $-8,805 | $-6,426 | $-1,173 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -70 | -59 | -218 | -177 | N/A |
| Investing Cash Flow | $-70 | $-59 | $-218 | $-177 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 7,000 | 4,000 | 8,000 | 6,000 | N/A |
| Common Stock Issued | N/A | N/A | 92 | N/A | N/A |
| Other Financing Activity | 0 | 0 | 0 | 92 | 1,500 |
| Financing Cash Flow | $7,000 | $4,000 | $8,092 | $6,092 | $1,500 |
| Exchange Rate Effect | N/A | 1 | -7 | -1 | N/A |
| Beginning Cash Position | 183 | 183 | 1,121 | 1,121 | 150 |
| End Cash Position | 68 | 1,114 | 183 | 609 | 477 |
| Net Cash Flow | $-115 | $931 | $-938 | $-512 | $327 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,045 | -3,011 | -8,805 | -6,426 | -1,173 |
| Capital Expenditure | -70 | -59 | -218 | -177 | N/A |
| Free Cash Flow | -7,115 | -3,070 | -9,023 | -6,603 | -1,173 |